Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2025 10:35 ET | Source: Research and Markets

Anamorelin Market Forecast Report 2025-2030: A Breakthrough Therapeutic Agent for Cachexia Treatment

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "Anamorelin Market by Indication (Cancer Cachexia, Chronic Heart Failure Cachexia, Future Indications), Distribution Channel (Emerging Channels,...
March 07, 2019 03:00 ET | Source: Helsinn Healthcare S.A.

Helsinn initiates two new global Phase III studies with anamorelin

Helsinn initiates two new global Phase III studies with anamorelin Helsinn committed to anamorelin which is being evaluated for weight loss and anorexia in patients with advanced non small cell lung...